SBI Funds Management Announces Change in Key Managerial Personnel: Devinder Pal Singh to Retire
Mr. Devinder Pal Singh, Joint CEO of SBI Funds Management, will retire due to superannuation on August 31, 2026. Ms. Vinaya Datar, Chief Compliance Officer, has confirmed the change. The company has updated its KMP list accordingly.
The departure of a KMP due to superannuation is a planned and expected event. The company has a clear succession plan with other KMPs in place, minimizing any significant impact on operations or business.
The announcement pertains to a standard retirement of a Key Managerial Personnel due to superannuation, which is a routine event and does not inherently carry a positive or negative financial implication for the company.
SBI Funds Management Limited has announced a change in its Key Managerial Personnel (KMP). Mr. Devinder Pal Singh, currently serving as Joint Chief Executive Officer, will cease to hold this position and will also retire as a KMP of the company. This cessation is effective from the closure of business hours on August 31, 2026, consequent to his attaining the age of superannuation.
Following Mr. Singh's departure, the company has updated its list of Key Managerial Personnel as per SEBI Listing Regulations. The revised list of KMPs, effective from August 31, 2026, includes Mr. Debasish Mishra (Managing Director and Chief Executive Officer), Mr. Denys Charles Jean Marie Fougeroux De Campigneulles (Executive Director and Deputy Chief Executive Officer), Mr. Inderjeet Ghuliani (Chief Financial Officer), and Ms. Vinaya Datar (Chief Compliance Officer, Company Secretary, and Head Legal).
The company has provided the requisite details as per SEBI Master Circular No. HO/49/14/14(7)2025 -CFD-POD2/I/3762/2026 dated January 30, 2026, which are enclosed as Annexure I. This intimation is also available on the company's website, https://sbifunds.com, in compliance with Regulation 46 of the SEBI Listing Regulations.
A plain-language summary of a public exchange filing by SBI Funds Management Limited. Read the original for the full detail.